ARWR
Arrowhead Pharmaceuticals
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ARWR fundamentals
Arrowhead Pharmaceuticals (ARWR) released its earnings on May 12, 2025: revenue was 542.71M (YoY 0.00%), beat estimates; EPS was 2.75 (YoY +369.61%), beat estimates.
Revenue / YoY
542.71M
0.00%
EPS / YoY
2.75
+369.61%
Report date
May 12, 2025
ARWR Earnings Call Summary for Q2,2025
- $1.375B Sarepta Deal Transforms Liquidity: Arrowhead funded through 2028 with $500M upfront, $325M equity, and $50M annual payments.
- Plozasiran on Track for 2025 Launch: 80% triglyceride reduction in FCS, 75% of patients <880 mg/dL, with U.S. PDUFA date November 18.
- Innovative Obesity Pipeline: Dual siRNA programs targeting visceral fat reduction with Phase 1 data expected late 2025.
- CNS Breakthrough Potential: First siRNA for Alzheimer's (ARO-MAPT) entering Phase 1, leveraging novel brain delivery platform.
- Strong Financial Position: $1.1B cash, $370M net income Q2, no equity dilution needed for commercialization.
EPS
Revenue
Revenue & Expenses
ARWR has released its 2025 Q2 earnings report, with revenue of 542.71M, reflecting a YoY change of NaN%, and net profit of 367.86M, showing a YoY change of 389.67%. The Sankey diagram below clearly presents ARWR's revenue sources and cost distribution.
Key Indicators
Arrowhead Pharmaceuticals (ARWR) key financial stats and ratios, covering profitability, financial health, and leverage.
Arrowhead Pharmaceuticals (ARWR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Arrowhead Pharmaceuticals (ARWR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Arrowhead Pharmaceuticals (ARWR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Arrowhead Pharmaceuticals (ARWR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Arrowhead Pharmaceuticals (ARWR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market’s earnings forecast for Arrowhead Pharmaceuticals next quarter?What guidance did Arrowhead Pharmaceuticals’s management provide for the next earnings period? How were Arrowhead Pharmaceuticals’s latest financial results overall?What were the key takeaways from Arrowhead Pharmaceuticals’s earnings call?What factors drove the changes in Arrowhead Pharmaceuticals’s revenue and profit?What does Arrowhead Pharmaceuticals do and what are its main business segments?What is Arrowhead Pharmaceuticals’s gross profit margin?Did Arrowhead Pharmaceuticals beat or miss consensus estimates last quarter?